Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Chiara Casarsa is active.

Publication


Featured researches published by Chiara Casarsa.


International Journal of Infectious Diseases | 2013

Disseminated tuberculosis in an immunocompetent patient

Filippo Mearelli; Ismet Burekovic; Michela Zanetti; Nicola Altamura; Giansante Carlo; Gianni Biolo; Stefano Cernic; Chiara Casarsa

Miliary tuberculosis refers to the clinical disease resulting from the hematogenous dissemination of Mycobacterium tuberculosis. A tuberculous aneurysm of the aorta is exceedingly rare. Contiguous tuberculosis in the form of lymphadenitis is generally responsible for the aortic involvement. We report a case of tuberculous mycotic aneurysm in patient with miliary disease, not affected by a cellular immunodeficiency and with no other common risk factor for infection. He received anti-tubercular therapy and endovascular stenting before the identification of Mycobacterium tuberculosis in lung, lymph nodes, and gastric lavage. The clinician should be aware that a mycotic abdominal aortic aneurysm could be caused by M. tuberculosis, even if microbiological confirmation is lacking or is negative, especially if a contiguous focus of tubercular infection is detected.


International Journal of Infectious Diseases | 2014

Invasive filamentous fungus infection with secondary cerebral vasculitis in a patient with no obvious immune suppression.

Filippo Mearelli; Alessandro Occhipinti; Nicola Altamura; Giovanni Fernandes; Giulia Pivetti; Enrico Chendi; Annalisa Spalluti; Lorenza Mamolo; Chiara Casarsa; Gianni Biolo

Invasive mold infections represent an emerging and important diagnostic challenge, especially in immunocompetent patients when microscopy and cultures of the biological fluids remain negative. A central nervous system localization is not common and the clinical presentation is aspecific.


American Journal of Case Reports | 2017

Septic Shock with Multi Organ Failure Due to Fluoroquinolones Resistant Campylobacter Jejuni

Filippo Mearelli; Chiara Casarsa; Andrea Breglia; Gianni Biolo

Patient: Male, 65 Final Diagnosis: Septic shock with MOF due to fluoroquinolones resistant Campylobacter jejuni Symptoms: Fever (37.4°C) • acute delirium Medication: — Clinical Procedure: — Specialty: Infectious Diseases Objective: Rare disease Background: Campylobacter jejuni infections are typically self-limited, and severe extra-intestinal complications are uncommon. Case Report: We report a case of a man with septic shock due to fluoroquinolones resistant Campylobacter jejuni. Conclusions: This manuscript emphasizes the potential lethality of fluorquinolones resistant Campylobacter jejuni bacteremia.


The Open Emergency Medicine Journal | 2013

Role of Angiopoietin-2 in Medical-Ward Patients with SIRS/Sepsis

Marina De Roia; Giulia Montanari; Nicola Altamura; Chiara Casarsa; Luigi Cattin; Gianni Biolo; Filippo Mearelli; Nicola Fiotti; Michela Zanetti; Daniele Orso; Tommaso Stefanucci; Antonella Nigro; Alessandra Iudicello; Denis Valentini; Silvia Marizza; Daniele Peric; Alessandro Occhipinti; Giovanni Fernandes; Irene Paoli

Background: SIRS/sepsis accounts for vast majority of deaths in ICU a medical ward department. More than 650,000 cases of sepsis are diagnosed in the United States annually, with 30-50% mortality and individually cost more than 22,000 dollars. Biomarkers could be useful tools for early risk stratification in these patients. Angiopioietin-2 (Ang-2) is a proinflamma- tory mediator of endothelial injury, which has received considerable attention over the past decade but little is known about its correlation with organ failure and mortality in SIRS/sepsis admitted to a medical ward. Methods: Ang-2 plasma levels, Charlson index, SOFA and routine laboratory test were carried out in 80 SIRS patients admitted to medical ward within 4 hours from diagnosis. Survival and organ dysfunction in the following week were recorded. Investigators were blinded from Ang-2 results. Results: Ang-2 plasma levels were higher in patients suffering from renal, pulmonary and hemostatic dysfunction (16, 6, 4% respectively) and patients who died within 1 week (11%). Ang-2 plasma levels higher than 15 ∝/mL account for 13 fold increased risk of death with 94% negative predictive value. Conclusions: Ang-2 plasma level at admission is predictive of early mortality and kidney, lung and hemostasis dysfunc- tion in SIRS/sepsis patients newly admitted in a medical ward.


Internal and Emergency Medicine | 2014

Heterogeneous models for an early discrimination between sepsis and non-infective SIRS in medical ward patients: a pilot study

Filippo Mearelli; Nicola Fiotti; Nicola Altamura; Michela Zanetti; Giovanni Fernandes; Ismet Burekovic; Alessandro Occhipinti; Daniele Orso; Carlo Giansante; Chiara Casarsa; Gianni Biolo


Critical Care | 2013

Procalcitonin, presepsin, pro-adrenomedullin, fibrin degradation products, and lactate in early diagnosis and prognosis of septic patients newly admitted to the intermediate care unit from the emergency department

Filippo Mearelli; Nicola Fiotti; Nicola Altamura; Irene Paoli; Chiara Casarsa; Maurizio Ruscio; Gianni Biolo


The American Journal of Medicine | 2017

Out of Place: Gallstone Ileus

Filippo Mearelli; Chiara Casarsa; Alberto Peretti; Francesca Spagnol; Antonio Giulio Gennari; Niccolò De Manzini; Gianni Biolo


Nutrition | 2018

High glutamine levels are related to increased mortality and blunted immune response in elderly septic patients

F.G. Di Girolamo; Nicola Fiotti; Luigi Maria Castello; Chiara Casarsa; Enrico Lupia; M.L. Mujesan; Claudio Ronco; S. Di Somma; Gian Carlo Avanzi; Filippo Mearelli; Gianni Biolo


Critical Care Medicine | 2018

Derivation and Validation of a Biomarker-Based Clinical Algorithm to Rule Out Sepsis From Noninfectious Systemic Inflammatory Response Syndrome at Emergency Department Admission: A Multicenter Prospective Study.

Filippo Mearelli; Nicola Fiotti; Carlo Giansante; Chiara Casarsa; Daniele Orso; Marco De Helmersen; Nicola Altamura; Maurizio Ruscio; Luigi Castello; Efrem Colonetti; Rossella Marino; Andrea Bregnocchi; Claudio Ronco; Enrico Lupia; Giuseppe Montrucchio; Maria Lorenza Muiesan; Salvatore Di Somma; Gian Carlo Avanzi; Gianni Biolo


F1000Research | 2017

Addressing empirical antimicrobial therapy in bacterial pneumonia: a new heterogeneous scoring system

Alessia Degrassi; Filippo Mearelli; Nicola Fiotti; Chiara Casarsa; Gianni Biolo

Collaboration


Dive into the Chiara Casarsa's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gianni Biolo

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gianni Biolo

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gian Carlo Avanzi

University of Eastern Piedmont

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge